Affiliation:
1. From the Department of Pharmacology, the Department of Physiology, and The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA.
Abstract
AbstractG12/13 or Gq signaling pathways activate platelet GPIIb/IIIa when combined with Gi signaling. We tested whether combined Gi and Gz pathways also cause GPIIb/IIIa activation and compared the signaling requirements of these events. Platelet aggregation occurred by combined stimulation of Gi and Gz pathways in human platelets and in P2Y1-deficient and Gαq-deficient mouse platelets, confirming that the combination of Gi and Gz signaling causes platelet aggregation. When Gi stimulation was combined with Gz stimulation, there was a small mobilization of intracellular calcium. Chelation of intracellular calcium decreased the extent of this platelet aggregation, whereas it abolished the Gq plus Gi-mediated platelet aggregation. Costimulation of Gi plus Gz pathways also caused thromboxane generation that was dependent on outside-in signaling and was inhibited by PP2, a Src family tyrosine kinase inhibitor. Src family tyrosine kinase inhibitors also inhibited platelet aggregation and decreased the PAC-1 binding caused by costimulation of Gi and Gz signaling pathways in aspirin-treated platelets. However, Src family kinase inhibitors did not affect Gq plus Gi-mediated platelet aggregation. We conclude that the combination of Gi plus Gz pathways have different requirements than Gq plus Gi pathways for calcium and Src family kinases in GPIIb/IIIa activation and thromboxane production.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献